For the third time, President Muhammadu Buhari has approved the extension of the second phase of the eased lockdown for another four weeks.
The Secretary to the Government of the Federation (SGF) and Chairman of the Presidential Task Force (PTF) on COVID-19 , Boss Mustapha disclosed this during the daily Task Force briefing in Abuja on Thursday.
The task force had met with President Buhari on Wednesday and briefed him on the progress made so far in containing the spread of COVID-19 and keeping citizens safe from contracting the virus.
Boss Mustapha while addressing newsmen today noted that the PTF made some recommendations to the president and the extension of the current ease of lockdown was one of the inferences approved.
The PTF chairman further disclosed that to sustain gains already made in the last few weeks, the task force recommended to President Buhari to retain the current phase of the response, with minor changes to address economic, socio-political, and health concerns.
According to him, the major changes being proposed are aimed at achieving the gradual re-opening of international air flights within established parameters. re-opening of rail transportation within established parameters, and the granting of permissions to exit classes to resume ahead of examinations.
Under the revised guidelines of the eased lockdown which will be maintained in the next four weeks, the current nationwide curfew from 10pm- 6am still stands.
Also, meetings for government officials and parastatals will continue to hold virtually.
While the ban on entertainment centers will be maintained, restrictions on recreational parks have been lifted for non-contact physical activities.
Passengers arriving for domestic flights can now arrive at least an hour and a half before flight, and three hours before the flight for international travelers.
The SGF however, reemphasized the need for everyone to take responsibility, and stop the stigmatization of persons who have contracted, been treated, and have been certified negative for COVID-19.